Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease research

Miron Sopic, Georgios Kararigas*, Yvan Devaux, Paolo Magni

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2143-2145
Number of pages3
JournalEuropean Heart Journal
Volume44
Issue number24
DOIs
Publication statusPublished - 12 Apr 2023

Bibliographical note

Funding Information:
M.S. is funded by the Ministarstvo obrazovanja, nauke i tehnoloskog razvoja, Republika Srbija through the Grant Agreement No: 451-03-9/2021-14/200161 with the University of Belgrade-Faculty of Pharmacy, European Union (AtheroNET COST Action CA21153; HORIZON-MSCA-2021-SE-01-01—MSCA Staff Exchanges 2021 CardioSCOPE 101086397, HORIZON-MSCA-2021-PF-MAACS 101064175). G.K. is funded by the Icelandic Research Fund (Grant No. 217946-051), a grant from the Icelandic Cancer Society Research Fund, and a grant from the University of Iceland Research Fund. Y.D. is funded by the EU Horizon 2020 project COVIRNA (Grant No. 101016072), the National Research Fund (Grant Nos. C14/BM/8225223, C17/BM/11613033, and COVID-19/2020-1/14719577/miRCOVID), CardioRNA COST Action (CA17129), the Ministry of Higher Education and Research, and the Heart Foundation—Daniel Wagner of Luxembourg. P.M. is funded by Universita’ degli Studi di Milano (Transition grant PSR2015-1720PMAGN_01; PSR 2021), Ministry of Health-IRCCS MultiMedica GR-2016-02361198, European Union (AtheroNET COST Action CA21153; HORIZON-MSCA-2021-SE-01-01—MSCA Staff Exchanges 2021 CardioSCOPE 101086397).

Funding Information:
This article is based on work from the AtheroNET COST Action CA21153 ( https://www.cost.eu/actions/CA21153/ ) funded by COST (European Cooperation in Science and Technology).

Other keywords

  • Humans
  • Cardiovascular Diseases
  • Multiomics
  • Atherosclerosis
  • Risk Factors

Cite this